3 trends tracked about this subject — the full history, oldest to newest below.
Ontario lowers the colorectal cancer screening age to 45, following shifts in clinical testing recommendations and national medical guidelines.
An upcoming FDA advisory panel review of seven peptide compounds has triggered scrutiny regarding potential conflicts of interest among selected experts.
Medical experts and researchers are increasingly focusing on the long-term implications, clinical efficacy, and industry shifts surrounding GLP-1 medications.